IP Library Granted Patent US 10,287,566
Granted Patent B2
US 10,287,566 · App. 15/406,876 · Granted May 14, 2019

DHAD variants and methods of screening

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,287,566
App. No.
15/406,876
Granted
May 14, 2019
Kind
B2
Abstract

Methods of screening for dihydroxy-acid dehydratase (DHAD) variants that display increased DHAD activity are disclosed, along with DHAD variants identified by these methods. Such enzymes can result in increased production of compounds from DHAD requiring biosynthetic pathways. Also disclosed are isolated nucleic acids encoding the DHAD variants, recombinant host cells comprising the isolated nucleic acid molecules, and methods of producing butanol.

Claims (24)

1. A method for the production of isobutanol comprising

(a) providing a recombinant host cell that comprises

(i) an isolated polypeptide having dihydroxy-acid dehydratase (DHAD) activity, wherein the polypeptide is at least 95% identical to a Streptococcus mutans DHAD of SEQ ID NO: 168 and comprises amino acid substitutions at position 33 and position 563, and

(ii) an isobutanol biosynthetic pathway, wherein the isobutanol biosynthetic pathway comprises the following substrate to product conversions:

(1) pyruvate to acetolactate catalyzed by an acetolactate synthase,

(2) acetolactate to 2,3-dihydroxyisovalerate catalyzed by a ketol-acid reductoisomerase,

(3) 2,3-dihydroxyisovalerate to α-ketoisovalerate catalyzed by DHAD,

(4) α-ketoisovalerate to isobutyraldehyde catalyzed by an α-keto acid decarboxylase, and

(5) isobutyraldehyde to isobutanol catalyzed by an alcohol dehydrogenase;

(b) culturing the recombinant host cell in a fermentation medium under suitable conditions to produce isobutanol; and

(c) recovering the isobutanol.

2. The method of claim 1 , wherein the recombinant host cell is a bacterial cell or a yeast cell.

3. The method of claim 2 , wherein the bacterial cell is a member of a genus of bacteria selected from Clostridium, Zymomonas, Escherichia, Salmonella, Rhodococcus, Pseudomonas, Bacillus, Lactobacillus, Enterococcus, Pediococcus, Alcaligenes, Klebsiella, Paenibacillus, Arthrobacter, Corynebacterium, Brevibacterium, Lactococcus, Leuconostoc, Oenococcus, Pediococcus , and Streptococcus.

4. The method of claim 2 , wherein the yeast cell is a member of a genus of yeast selected from Saccharomyces, Schizosaccharomyces, Hansenula, Kluyveromyces, Candida, Pichia , and Yarrowia.

5. The method of claim 1 , wherein the recovering is by distillation, liquid-liquid extraction, adsorption, gas stripping, decantation, membrane evaporation, pervaporation, or combinations thereof.

6. The method of claim 5 , wherein the recovering is by liquid-liquid extraction and the extractant is derived from biomass.

7. The method of claim 1 , further comprising removing solids from the fermentation medium.

8. The method of claim 7 , wherein the removing is by centrifugation, filtration, decantation, or combinations thereof.

9. The method of claim 7 , wherein the removing occurs before the recovering.

10. The method of claim 1 , wherein the recombinant host cell comprises the polypeptide of SEQ ID NO: 534.

11. The method of claim 1 , wherein the recombinant host cell further comprises a disruption in an endogenous gene that encodes a mitochrondrial DHAD.

12. The method of claim 1 , wherein the recombinant host cell further comprises a disruption in one or more endogenous genes affecting iron-sulfur cluster biosynthesis selected from FRA2, GRX3, and GRX4.

13. The method of claim 1 , wherein the recombinant host cell has been further genetically engineered to upregulate the activity of at least one gene selected from AFT1 and AFT2.

14. The method of claim 1 , wherein the recombinant host cell has been further genetically modified to disrupt a gene encoding pyruvate decarboxylase (PDC).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2021
From: BUTAMAX ADVANCED BIOFUELS LLC
To: GEVO, INC.
Reel/Frame 057677/0477 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2021
From: KELLY, KRISTEN J.; YE, RICK W.
To: BUTAMAX ADVANCED BIOFUELS LLC
Reel/Frame 057296/0785 →
Cited By (1)
US 12,203,104